Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning

Pharmaceutical Research

Volumn 20, Issue 5, 2003, Pages 810-817

  Verreck, Geert ^a   Chun, Iksoo ^b   Peeters, Jef ^a   Rosenblatt, Joel ^b   Brewster, Marcus E ^a  

^a A Division of Johnson Johnson   (Belgium)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

Amorphous solid dispersion; Electrostatic spinning; Improved dissolution rate; Itraconazole

Indexed keywords

ALCOHOL; DICHLOROMETHANE; HYDROXYPROPYLMETHYLCELLULOSE; ITRACONAZOLE; NANOFIBER; POLYMER; SOLVENT;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG SOLUBILITY; DRUG STRUCTURE; ELECTRONICS; ELECTROSTATIC SPINNING; MELTING POINT; MOLECULAR WEIGHT; PARTITION COEFFICIENT; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID; SOLUBILITY;

CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DELIVERY SYSTEMS; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTROSTATICS; ITRACONAZOLE; MICROSCOPY, ELECTRON, SCANNING; NANOTECHNOLOGY;

EID: 0242417139     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023450006281     Document Type: Article

References (31)

1. R. A. Prentis, Y. Lis, and S. R. Walker. Pharmaceutical innovation by seven UK-owned pharmaceutical companies (1964-1985). Br. J. Clin. Pharmacol. 25:387-396 (1988).
2. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:3-25 (1997).
3. C. A. Lipinski. Avoiding investment in doomed drugs. Curr. Drug Discov. 1:17-19 (2001).
4. A. A. Noyes and W. R. Whitney. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc. 19:930-934 (1897).
5. D. E. Wurster and P. W. Taylor. Dissolution rates. J. Pharm. Sci. 54:169-175 (1965).
6. S. M. Grant and S. P. Clissold. Itraconazole. Drugs 37:310-344 (1989).
7. K. De Beule, and J. Van Gestel. Pharmacology of itraconazole. Drugs 61(Suppl. 1):27-33 (2001).
8. S. Jain and V. Seghal. Itraconazole: an effective oral antifungal for onchomychosis. Int. J. Dermatol. 40:1-5 (2001).
9. J. Peeters, P. Neeskens, J. P. Tollenaere, P. Van Remoortere, and M. E. Brewster. Characterization of the interaction of 2-hydroxypropyl-β-cyclodextrin with itraconazole at pH 2, 4 and 7. J. Pharm. Sci. 91:1414-1422 (2002).
10. P. Sheen, V. Khetarpal, C. Cariola, and C. Rowlings. Formulation of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int. J. Pharm. 118:221-227 (1995).
11. A. T. Serajuddin. Solid dispersion of poorly water-soluble drugs. Early promises, subsequent problems and recent breakthroughs. J. Pharm. Sci. 88:1058-1066 (1999).
12. C. Leuner, and J. Dressman. Improving drug solubility for oral delivery using solid dispersion. Eur. J. Pharm. Biophann. 50:47-60 (2000).
13. D. Erkoboni and R. Andersen. Improved aqueous solubility pharmaceutical formulation. World Patent 0056726 (2000).
14. P. A. Gilis, V. De Conde, and R. Vandecruys. Beads having a core coated with an antifungal and a polymer. US Patent 5633015 (1997).
15. L. Baert, D. Thone, and G. Verreck. Antifungal compositions with improved bioavailability. World Patent 9744014 (1997).
16. D. H. Reneker and I. Chun. Nanometre diameter of polymer, produced by electrospinning. Nanotechnology 7:216-223 (1996).
17. J. Doshi and D. H. Reneker. Electrospinning process and applications of electrospun fibers. J. Electrostatics 35:151-160 (1995).
18. E. R. Kenawy, G. L. Bowlin, K. Mansfield, J. Layman, D. G. Simpson, E. H. Sanders, and G. E. Wnek. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J. Control, Release 81:57-64 (2002).
19. F. Ignatious and J.M. Baldoni. Electrospun pharmaceutical compositions. World Patent 0154667 (2001).
20. A. L. Yarin, S. Koombhongse, and D. H. Reneker. Taylor cone and jetting from liquid droplets in electrospinning of nanofibers. J. Appl. Phys. 90:4836-4846 (2001).
21. A. L. Yarin, S. Koombhongse, and D. H. Reneker. Bending instability in electrospinning of nanofibers. J. Appl. Phys. 89:3018-3026 (2001).
22. J. M. Deitzel, J. Kleinmeyer, D. Harris, and N. C. Beck Tan. The effect of processing variables on the morphology of electrospun nanofibers and textiles. Polymers 42:261 (2001).
23. th Annual Meeting for the Society for Biomaterials, 143 (2002).
24. K. Six, G. Verreck, J. Peeters, K. Binnemans, K. Bergmans, P. Augustijns, R. Kinget, and G. Van den Mooter. Investigation of thermal properties of glassy itraconazole: identification of monotropic mesophase. Thennochim. Acta 376:175-181 (2001).
25. F. N. Kelley and F. Bueche. Viscosity and glass-transition temperature relations for polymer-dilute systems. J. Poly. Sci. 50: 549-556 (1961).
26. M. Gordon and J. S. Taylor. Ideal copolymers and the second-order transitions of synthetic rubbers. I. Noncrystalline copolymers. J. Appl. Chem. 2:493-500 (1952).
27. R. Simha and R. F. Boyer. General relation involving the glass temperature and coefficients of expansion of polymers. J. Chem. Phys. 37:1003-1007 (1962).
28. T. Kissel, M. A. Rummelt, and H. P. Bier. Wirkstoffreisetzung aus bioabbaubaren Mikropartikeln. Dtsch. Apoth. Ztg. 133:29-32 (1993).
29. G. Verreck, L. Baert, J. Peeters, and M. Brewster. Improving aqueous solubility and bioavailability for itraconazole by solid dispersion approach. AAPSPharmSci 3:M2157 (2001).
30. K. Six, C. Leuner, J. Dressman, G. Verreck, J. Peeters, N. Blaton, P. Augustijns, R. Kinget, and G. Van den Mooter. Thermal properties of hot-stage extrudates of itraconazole and Eudragit E100. Phase separation and polymorphism. J. Thermal Anal. Calorimetry 68:591-601 (2002).
31. L. Baert, J. Peeters and G. Verreck. Solid mixtures of cyclodextrins prepared via melt-extrusion. World Patent 9718839 (1997).